Golden Max LLC

Golden Max LLC, a Missouri City, Texas-based for-profit limited liability company, supplies medical capital equipment and infusion pump systems to the Department of Defense as a prime contractor on a single massive IDIQ vehicle and as a subcontractor to major medical distributors, competing on full-and-open basis without set-asides. The vendor is not an SBA-certified small business, minority-owned enterprise, or HUBZone firm; it operates as a standard commercial entity in the medical equipment wholesale and distribution space (primary NAICS 424210 — Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers; PSC imaging equipment and medical/surgical supplies).

Golden Max's federal footprint is almost entirely concentrated on a single parent vehicle: the Defense Logistics Agency Troop Support Medical Indefinite Delivery Contract SPE2D122D0005, a $147.6 million IDIQ awarded November 3, 2021, on full-and-open competitive basis without set-aside, covering medical capital equipment procurement supporting DoD healthcare infrastructure across military treatment facilities worldwide. The vendor holds 1,887 task orders (delivery orders and purchase orders) under this single IDIQ with $63.6 million in combined potential value. Over the past five years, Golden Max has accumulated 2,130 total awards (prime and sub combined) with $263.4 million combined potential value; activity accelerated from 192 awards in 2022 to a peak of 682 in 2024, then moderated to 602 in 2025 and 192 year-to-date in 2026. Only $80.1 million of the $263.4 million in potential value has been obligated to date (30%), indicating the portfolio consists largely of ceiling values across many small delivery orders rather than executed spend.

The vendor's customer concentration is extreme: Defense Logistics Agency Troop Support Medical accounts for 2,018 of 2,105 awards (99% coverage) and $210.5 million of $263.4 million combined potential value (80% concentration). The Department of the Army Medical Command trails far behind at 15 awards and $48.8 million, followed by the Defense Health Agency (6 awards, $2.2 million), the Department of the Navy Bureau of Medicine and Surgery (2 awards, $896 thousand), and GSA Federal Acquisition Service (16 awards, $550 thousand). This concentration reflects Golden Max's narrow competitive positioning as a specialized supplier of Infusomat Space and Perfusor Space infusion pumps, blood pump sets with Caresite injection compatibility, medical administration sets, power supplies, battery packs, infusion pump accessories (speed clamps, lead cables, service connectors), and related medical capital equipment components — all procured on delivery orders ranging from tens of dollars to over $278,000 per order.

Golden Max operates 100% of performance out of its Missouri City, Texas facility with no geographic diversification. All delivery orders under the primary IDIQ specify Missouri City as place of performance. The vendor's recent award activity (March through April 2026) reflects dozens of small delivery orders for individual infusion pump components — motherboards, door bolts, power supplies, battery packs, administration sets — each valued under $10,000, alongside several larger orders for complete 3-channel intravenous infusion pumps and Akkumodul SP pin assemblies valued $27,000 to $278,000. This order pattern suggests Golden Max functions as a just-in-time medical equipment distributor and repair-parts supplier to the DLA Medical Supply Chain organization rather than a bulk procurement contractor.

In its subcontractor role (7% of total awards, or 153 sub awards), Golden Max engages primarily as a medical equipment supplier to Cardinal Health 200, LLC across dozens of small sub-awards for medical/surgical equipment and supplies — chest vent seals, combat tourniquets, catheters, surgical instruments, and implantable ports — awarded between October 2025 and January 2026. The subcontract work to Cardinal Health appears narrower and more tactical than the prime work and does not anchor to a named IDV or parent vehicle in the source.

Only eight awards face ultimate completion in the next twenty-four months with combined potential value of $2.1 million, suggesting minimal recompete cliff exposure. The parent IDIQ SPE2D122D0005 itself expires November 3, 2026, placing the entire vehicle in recompete window — a material risk for Golden Max if DLA opens the vehicle to competition or consolidates suppliers. Golden Max's narrow focus on a single vehicle and single customer (DLA Troop Support Medical) creates significant customer concentration and vehicle-loss risk despite the absolute dollar magnitude of the prime portfolio.